Overview
Biocorpo is a Polish contract manufacturer of dietary supplements and foods for special medical purposes, with over 20 years of experience. It develops product formulas and processes, conducts technological trials and stability tests, prepares quality documentation, and assists with dietary supplement registration. It also makes supplements and complementary feed mixes for pets in forms including tablets, capsules, liquids, and powders.
Financials
The financial statement for 2022 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2021.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2004-09-01. Active
04 1090 1030 0000 0001 0019 6959- 33 1090 1030 0000 0001 2057 4197
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
4 public aid cases recorded, with a total value of $11,642.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 28, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $4,286$4,286 | Prezes Banku Gospodarstwa Krajowego | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,558$2,558 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,997$1,997 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Trademarks
Biocorpo holds 1 active trademark registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2004.
| Mark | Protected until | |
|---|---|---|
| BIOCORPO SP. Z O.O. | May 23, 2027 | |
| LAKCILlus | – | |
| LIBIGRA(word) | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board acting independently; in the case of a multi-member management board, two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ewa Jolanta Koziorowska (79) | 50 | $13,506.21 | 50% |
Stefan Michał Koziorowski (89) | 50 | $13,506.21 | 50% |
Ewa Jolanta Koziorowska and Stefan Michał Koziorowski hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Supplelabsp. z o.o. + limited partnership | $5,146,355.45 | supplelab.pl | ||
| BIOUsp. z o.o. | $2,620,263.35 | biou.pl | ||
| EkspolS.A. | $2,318,767.06 | ekspol.com | ||
| Amileksp. z o.o. | $1,792,976.38 | amilek.pl | ||
| Lab88sp. z o.o. | $1,707,981.35 | lab88.pl | ||
| Nutri Partnersp. z o.o. | $1,480,720.01 | nutri-partner.com | ||
| Gotabsp. z o.o. | $1,433,720.57 | gotab.pl | ||
| Auralab360sp. z o.o. | $1,385,659.31 | auralab360.pl | ||
| Methodo Polskasp. z o.o. | $1,337,205.31 | methodopolska.com | ||
| IOCsp. z o.o. | $878,940.46 | producentsuplementow.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-12 | Address change (Bytomska 11, 01-612, Warszawa → Ul. Wólczyńska 232, 01-919, Warszawa) | |
| 2005-07-09 | Name change (K & K Medicplast → Biocorpo) | |
| 2004-08-11 | Address change (Wólczyńska 232, 01-919, Warszawa → Bytomska 11, 01-612, Warszawa) | |
| 2002-04-03 | Entered in the register |
FAQ
Last updated: 2026-04-04